4//SEC Filing
RYLL TIMOTHY D 4
Accession 0001181431-07-041116
CIK 0001310094other
Filed
Jun 18, 8:00 PM ET
Accepted
Jun 19, 5:05 PM ET
Size
8.7 KB
Accession
0001181431-07-041116
Insider Transaction Report
Form 4
RYLL TIMOTHY D
10% Owner
Transactions
- Award
Common Stock Warrant (right to buy)
2007-06-15+2,000,000→ 2,000,000 total(indirect: By LLC)Exercise: $4.32From: 2007-06-15Exp: 2011-06-14→ Common Stock (2,000,000 underlying) - Award
Common Stock Warrant (right to buy)
2007-06-15+200,000→ 200,000 total(indirect: By MOAB Investment, LP)Exercise: $4.32From: 2007-06-15Exp: 2011-06-14→ Common Stock (200,000 underlying)
Footnotes (3)
- [F1]Represents transaction(s) by MOAB Investments, LP. Mr. Ryll is the sole shareholder and sole director of MOAB Management Company, Inc., which is the sole general partner of MOAB Investments, LP. Mr. Ryll disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
- [F2]Represents transaction(s) by Hopkins Capital Group II, LLC (HCG II). MOAB Investments, LP is a member of HCG II. Mr. Ryll is the sole shareholder and sole director of MOAB Management Company, Inc., which is the sole general partner of MOAB Investments, LP. Mr. Ryll disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
- [F3]Represents warrants granted in consideration of personal guarantees and/or personal asset pledges by the reporting person to secure and support the issuer's credit factilities
Documents
Issuer
ACCENTIA BIOPHARMACEUTICALS INC
CIK 0001310094
Entity typeother
Related Parties
1- filerCIK 0001331297
Filing Metadata
- Form type
- 4
- Filed
- Jun 18, 8:00 PM ET
- Accepted
- Jun 19, 5:05 PM ET
- Size
- 8.7 KB